{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Covid-19",
      "Genetic variation",
      "High-throughput nucleotide sequencing",
      "SARS-CoV-2",
      "SARS-CoV-2 variants",
      "Whole genome sequencing"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34933126",
  "DateCompleted": {
    "Year": "2022",
    "Month": "01",
    "Day": "27"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "08"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "12",
        "Day": "18"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.meegid.2021.105192",
      "S1567-1348(21)00492-5"
    ],
    "Journal": {
      "ISSN": "1567-7257",
      "JournalIssue": {
        "Volume": "97",
        "PubDate": {
          "Year": "2022",
          "Month": "Jan"
        }
      },
      "Title": "Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases",
      "ISOAbbreviation": "Infect Genet Evol"
    },
    "ArticleTitle": "Mutation profile of SARS-CoV-2 genome in a sample from the first year of the pandemic in Colombia.",
    "Pagination": {
      "StartPage": "105192",
      "MedlinePgn": "105192"
    },
    "Abstract": {
      "AbstractText": [
        "The severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is the etiopathogenic agent of COVID-19, a condition that has led to a formally recognized pandemic by March 2020 (World Health Organization -WHO). The SARS-CoV-2 genome is constituted of 29,903 base pairs, that code for four structural proteins (N, M, S, and E) and more than 20 non-structural proteins. Mutations in any of these regions, especially in those that encode for the structural proteins, have allowed the identification of diverse lineages around the world, some of them named as Variants of Concern (VOC) and Variants of Interest (VOI), according to the WHO and CDC. In this study, by using Next Generation Sequencing (NGS) technology, we sequenced the SARS-CoV-2 genome of 422 samples from Colombian residents, all of them collected between April 2020 and January 2021. We obtained genetic information from 386 samples, leading us to the identification of 14 new lineages circulating in Colombia, 13 of which were identified for the first time in South America. GH was the predominant GISAID clade in our sample. Most mutations were either missense (53.6%) or synonymous mutations (37.4%), and most genetic changes were located in the ORF1ab gene (63.9%), followed by the S gene (12.9%). In the latter, we identified mutations E484K, L18F, and D614G. Recent evidence suggests that these mutations concede important particularities to the virus, compromising host immunity, the diagnostic test performance, and the effectiveness of some vaccines. Some important lineages containing these mutations are the Alpha, Beta, and Gamma (WHO Label). Further genomic surveillance is important for the understanding of emerging genomic variants and their correlation with disease severity."
      ],
      "CopyrightInformation": "Copyright \u00a9 2021 The Authors. Published by Elsevier B.V. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Genuino Research Group, Gencell Pharma, Colombia."
          }
        ],
        "LastName": "G\u00e1lvez",
        "ForeName": "Jubby Marcela",
        "Initials": "JM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Genuino Research Group, Gencell Pharma, Colombia; Clinical Investigation Group, Universidad del Rosario, Colombia; Hospital Universitario Mayor - M\u00e9deri, Colombia."
          }
        ],
        "LastName": "Chaparro-Solano",
        "ForeName": "Henry Mauricio",
        "Initials": "HM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Clinical Investigation Group, Universidad del Rosario, Colombia."
          }
        ],
        "LastName": "Pinz\u00f3n-Rond\u00f3n",
        "ForeName": "\u00c1ngela Mar\u00eda",
        "Initials": "\u00c1M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Fundaci\u00f3n Valle del Lili, Colombia."
          }
        ],
        "LastName": "Albornoz",
        "ForeName": "Ludwig L",
        "Initials": "LL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Clinical Investigation Group, Universidad del Rosario, Colombia; Hospital Universitario Mayor - M\u00e9deri, Colombia."
          }
        ],
        "LastName": "Pardo-Oviedo",
        "ForeName": "Juan Mauricio",
        "Initials": "JM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Genuino Research Group, Gencell Pharma, Colombia."
          }
        ],
        "LastName": "Zapata-G\u00f3mez",
        "ForeName": "Fabio Andr\u00e9s",
        "Initials": "FA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Clinical Investigation Group, Universidad del Rosario, Colombia."
          }
        ],
        "LastName": "Pati\u00f1o-Aldana",
        "ForeName": "Andr\u00e9s Felipe",
        "Initials": "AF"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universidad del Rosario, Colombia."
          }
        ],
        "LastName": "Hern\u00e1ndez-Rodr\u00edguez",
        "ForeName": "Andrea Del Pila",
        "Initials": "ADP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universidad del Rosario, Colombia."
          }
        ],
        "LastName": "D\u00edaz-Quiroz",
        "ForeName": "Mateo",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Clinical Investigation Group, Universidad del Rosario, Colombia. Electronic address: angela.ruiz@urosario.edu.co."
          }
        ],
        "LastName": "Ruiz-Sternberg",
        "ForeName": "\u00c1ngela Mar\u00eda",
        "Initials": "\u00c1M"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Infect Genet Evol",
    "NlmUniqueID": "101084138",
    "ISSNLinking": "1567-1348"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "ORF1ab polyprotein, SARS-CoV-2"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Polyproteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Spike Glycoprotein, Coronavirus"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Viral Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "spike protein, SARS-CoV-2"
    }
  ],
  "SupplMeshList": [
    "SARS-CoV-2 variants"
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "epidemiology",
        "transmission",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Colombia"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Epidemiological Monitoring"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Evolution, Molecular"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Gene Expression"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genome, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mutation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Phylogeny"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Polyproteins"
    },
    {
      "QualifierName": [
        "classification",
        "genetics",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Spike Glycoprotein, Coronavirus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Time Factors"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Viral Proteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Whole Genome Sequencing"
    }
  ],
  "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."
}